• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    11/14/25 4:07:44 PM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Alignment Healthcare, Inc.

    (Name of Issuer)


    Common Stock, par value $0.001 per share (the "Shares")

    (Title of Class of Securities)


    01625V104

    (CUSIP Number)


    09/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Citadel Advisors LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    5,951,410.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    5,951,410.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,951,410.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.0 %
    12Type of Reporting Person (See Instructions)

    IA, HC, OO

    Comment for Type of Reporting Person:  The percentages reported in this Schedule 13G are based upon 198,031,417 Shares outstanding as of July 25, 2025 (according to the issuer's Form 10-Q as filed with the Securities and Exchange Commission on July 30, 2025).


    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Citadel Advisors Holdings LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    5,951,410.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    5,951,410.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,951,410.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.0 %
    12Type of Reporting Person (See Instructions)

    HC, PN


    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Citadel GP LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    5,951,410.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    5,951,410.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,951,410.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.0 %
    12Type of Reporting Person (See Instructions)

    HC, OO


    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Citadel Securities LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    695,842.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    695,842.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    695,842.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.4 %
    12Type of Reporting Person (See Instructions)

    BD, OO


    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Citadel Securities Group LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    766,597.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    766,597.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    766,597.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.4 %
    12Type of Reporting Person (See Instructions)

    HC, PN


    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Citadel Securities GP LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    766,597.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    766,597.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    766,597.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.4 %
    12Type of Reporting Person (See Instructions)

    HC, OO


    SCHEDULE 13G

    CUSIP No.
    01625V104


    1Names of Reporting Persons

    Kenneth Griffin
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    6,718,007.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    6,718,007.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,718,007.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.4 %
    12Type of Reporting Person (See Instructions)

    HC, IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Alignment Healthcare, Inc.
    (b)Address of issuer's principal executive offices:

    1100 W. Town and Country Road, Suite 1600, Orange, CA, 92868
    Item 2. 
    (a)Name of person filing:

    This Schedule 13G is being jointly filed by Citadel Advisors LLC ("Citadel Advisors"), Citadel Advisors Holdings LP ("CAH"), Citadel GP LLC ("CGP"), Citadel Securities LLC ("Citadel Securities"), Citadel Securities Group LP ("CALC4"), Citadel Securities GP LLC ("CSGP") and Mr. Kenneth Griffin (collectively with Citadel Advisors, CAH, CGP, Citadel Securities, CALC4 and CSGP, the "Reporting Persons") with respect to the Shares of the above-named issuer owned by Citadel Multi-Strategy Equities Master Fund Ltd., a Cayman Islands company ("CM"), CRBU Holdings LLC, a Delaware limited liability company ("CRBH"), and Citadel Securities. Such owned Shares may include other instruments exercisable for or convertible into Shares. Citadel Advisors is the portfolio manager for CM. CAH is the sole member of Citadel Advisors. CGP is the general partner of CAH. CALC4 is the non-member manager of Citadel Securities and CRBH. CSGP is the general partner of CALC4. Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP. The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).
    (b)Address or principal business office or, if none, residence:

    The address of each of the Reporting Persons is 830 Brickell Plaza, Miami, Florida 33131.
    (c)Citizenship:

    Each of Citadel Advisors, CGP, Citadel Securities and CSGP is organized as a limited liability company under the laws of the State of Delaware. Each of CALC4 and CAH is organized as a limited partnership under the laws of the State of Delaware. Mr. Griffin is a U.S. citizen.
    (d)Title of class of securities:

    Common Stock, par value $0.001 per share (the "Shares")
    (e)CUSIP No.:

    01625V104
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    1. Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own 5,951,410 Shares. 2. Citadel Securities LLC may be deemed to beneficially own 695,842 Shares. 3. Each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to beneficially own 766,597 Shares. 4. Mr. Griffin may be deemed to beneficially own 6,718,007 Shares.
    (b)Percent of class:

    1. The number of Shares that each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own constitutes 3.0% of the Shares outstanding. 2. The number of Shares that Citadel Securities LLC may be deemed to beneficially own constitutes 0.4% of the Shares outstanding. 3. The number of Shares that each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to beneficially own constitutes 0.4% of the Shares outstanding. 4. The number of Shares that Mr. Griffin may be deemed to beneficially own constitutes 3.4% of the Shares outstanding.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    1. Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC: 0 2. Citadel Securities LLC: 0 3. Each of Citadel Securities Group LP and Citadel Securities GP LLC: 0 4. Mr. Griffin: 0

     (ii) Shared power to vote or to direct the vote:

    1. Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC: 5,951,410 2. Citadel Securities LLC: 695,842 3. Each of Citadel Securities Group LP and Citadel Securities GP LLC: 766,597 4. Mr. Griffin: 6,718,007

     (iii) Sole power to dispose or to direct the disposition of:

    1. Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC: 0 2. Citadel Securities LLC: 0 3. Each of Citadel Securities Group LP and Citadel Securities GP LLC: 0 4. Mr. Griffin: 0

     (iv) Shared power to dispose or to direct the disposition of:

    1. Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC: 5,951,410 2. Citadel Securities LLC: 695,842 3. Each of Citadel Securities Group LP and Citadel Securities GP LLC: 766,597 4. Mr. Griffin: 6,718,007

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Citadel Advisors LLC
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, Authorized Signatory
    Date:11/14/2025
     
    Citadel Advisors Holdings LP
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, Authorized Signatory
    Date:11/14/2025
     
    Citadel GP LLC
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, Authorized Signatory
    Date:11/14/2025
     
    Citadel Securities LLC
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, Authorized Signatory
    Date:11/14/2025
     
    Citadel Securities Group LP
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, Authorized Signatory
    Date:11/14/2025
     
    Citadel Securities GP LLC
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, Authorized Signatory
    Date:11/14/2025
     
    Kenneth Griffin
     
    Signature:/s/ Seth Levy
    Name/Title:Seth Levy, attorney-in-fact*
    Date:11/14/2025

    Comments accompanying signature:  * Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.
    Get the next $ALHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    10/14/2025$21.00Buy
    Goldman
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    5/30/2024$7.75 → $11.00Neutral → Buy
    BofA Securities
    5/8/2024$6.00 → $8.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $ALHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/25 4:07:44 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by Alignment Healthcare Inc.

    SCHEDULE 13G - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/25 9:33:32 AM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 144 filed by Alignment Healthcare Inc.

    144 - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/10/25 4:18:28 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Konowiecki Joseph S sold $79,680 worth of shares (4,832 units at $16.49), decreasing direct ownership by 0.44% to 1,081,141 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    11/12/25 6:30:17 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Chief Executive Officer Kao John E sold $2,936,772 worth of shares (180,000 units at $16.32) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    11/12/25 6:28:06 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Director Konowiecki Joseph S sold $450,000 worth of shares (25,000 units at $18.00), decreasing direct ownership by 2% to 1,085,973 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    10/28/25 6:48:40 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Alignment Healthcare with a new price target

    Goldman initiated coverage of Alignment Healthcare with a rating of Buy and set a new price target of $21.00

    10/14/25 8:46:39 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Alignment Healthcare from Sector Weight to Overweight and set a new price target of $21.00

    8/25/25 8:07:20 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by Barclays with a new price target

    Barclays upgraded Alignment Healthcare from Underweight to Equal Weight and set a new price target of $13.00

    7/31/25 8:54:42 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    3/18/24 5:27:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference

    ORANGE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the Piper Sandler 37th Annual Healthcare Conference in New York on Wednesday, Dec. 3, at 10 a.m. EST. A webcast and replay of the presentations will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage

    11/19/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics

    Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDAHas 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its third quarter ended September 30, 2025. "Our third quarter results mark the third consecutive quarter in which we surpassed the high end of our guidance across all

    10/30/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report

    ORANGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, has been named a 2026 Best Insurance Company for Medicare Advantage by U.S. News & World Report in all five states where it operates: Arizona, California, Nevada, North Carolina and Texas. "We're proud to be named a Best Insurance Company for Medicare Advantage in every state we serve and for multiple years running," said Dawn Maroney, CEO of Alignment Health Plan and president, Alignment Health. "This honor reflects how our approach to senior care continues to stand out: delivering exceptional products, improved outcomes and outstanding member care

    10/22/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Leadership Updates

    Live Leadership Updates

    View All

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

    ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose member companies provide health care coverage, services and solutions to millions of Americans every day. "I'm honored to join the AHIP board and collaborate with leaders across the industry who are committed to making health care work better for more Americans," said Kao. "The industry is at a critical inflection point, and I look forward to working with my fellow board members to help shape a stronger, more sustainable future for everyone

    6/10/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Appoints Sebastian Burzacchi to New Role of Chief Operating Officer of Management Services Organization and Andreas Wagner to Chief People Officer

    ORANGE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Sebastian Burzacchi will join as the new chief operating officer of its management services organization (MSO), and Andreas Wagner will serve as chief people officer, effective immediately. Sebastian Burzacchi, Chief Operating Officer of MSOReporting to Alignment founder and CEO John Kao, Sebastian Burzacchi will direct initiatives that strengthen a core value of the company – supporting doctors. This includes a focus on enhancing provider partnerships and ensuring a seamless experience for doctors with Alignment. "We are thrilled to welcome Sebastian to our leadership team, br

    1/9/24 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Financials

    Live finance-specific insights

    View All

    Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics

    Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDAHas 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its third quarter ended September 30, 2025. "Our third quarter results mark the third consecutive quarter in which we surpassed the high end of our guidance across all

    10/30/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025

    ORANGE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its third quarter 2025 financial results on Thursday, Oct. 30, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/ov96m6yi A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will

    10/2/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics

    Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises full-year outlook across same four metrics ORANGE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its second quarter ended June 30, 2025. "In today's Medicare Advantage environment, Alignment Healthcare's second quarter performance proves that strong financial results and high-quality care can go hand in hand – with the right model," said John Kao, found

    7/30/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/24 1:26:14 PM ET
    $ALHC
    Medical Specialities
    Health Care